MedTrace Logo

Association Between Preoperative HALP and Immediate Postoperative Outcomes

NCT05506748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2022-08-18

No results posted yet for this study

Summary

Multiple inflammation-based prognostic scores have been developed for the prediction of perioperative morbidity and mortality following pancreaticoduodenectomy (PD). Preoperative "Hemoglobin, Albumin, Lymphocytes and Platelets index (HALP)" is one of the promising inflammatory markers that has emerged as a predictor of postoperative survival. To date, no study has been done with preoperative HALP to predict 30days morbidity and mortality.

Is there any association between Preoperative HALP (hemoglobin, albumin, lymphocyte, and platelet) and 30 days post operative morbidity and mortality in patients undergoing Pancreaticoduodenectomy?

Conditions

  • Hemoglobins
  • Albumins
  • Platelets
  • Lymphocytes
  • Morbidity
  • Mortality
  • Whipples Procedure

Interventions

OTHER

pantients undergoing pancreaticoduodenectomy

The study includes all the cases who underwent pancreaticoduodenectomy for carcinoma head of the pancreas, distal cholangiocarcinoma, periampullary and duodenal cancer.

Sponsors & Collaborators

  • Chitwan Medical College

    lead OTHER

Principal Investigators

  • Harish Neupane, MBBS, MS · Chitwan Medical Hospital

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-20
Primary Completion
2022-04-20
Completion
2022-04-20

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05506748 on ClinicalTrials.gov